|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 405/04 | (2006.01) |
| C07D 413/04 | (2006.01) | ||
| C07D 417/04 | (2006.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61K 31/55 | (2006.01) |
| (11) | Patento numeris | 3661929 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18756100.6 |
| Europos patento paraiškos padavimo data | 2018-08-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/044854 |
| Data | 2018-08-01 |
| (87) | Numeris | WO 2019/028165 |
| Data | 2019-02-07 |
| (30) | Numeris | Data | Šalis |
| 201762540249 P | 2017-08-02 | US |
| (72) |
BOWEN, Carrie, A. , US
BURDI, Douglas, F. , US
HEFFERNAN, Michele, L., R. , US
HERMAN, Lee, W. , US
XIE, Linghong , US
|
| (73) |
Sunovion Pharmaceuticals Inc. ,
84 Waterford Drive, Marlborough, MA 01752,
US
PGI Drug Discovery LLC , 215 College Road, Paramus, NJ 07652, US |
| (54) | ISOCHROMAN COMPOUNDS AND USES THEREOF |
| ISOCHROMAN COMPOUNDS AND USES THEREOF |